Michael Brooks
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Michael Brooks currently works at Edesa Biotech, Inc., as President from 2019.
Dr. Brooks also formerly worked at Cipher Pharmaceuticals, Inc., as Director-Business Development from 2010 to 2015, Edesa Biotech, Inc. (Old), as President, and Edesa Biotech Research, Inc., as Vice President-Corporate Development & Strategy.
Dr. Brooks received his Masters Business Admin degree from Rotman School of Management and undergraduate degree and doctorate degree from the University of Toronto.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EDESA BIOTECH, INC. 3.28% | 2026-05-26 | 291,479 ( 3.28% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| EDESA BIOTECH, INC. | President | 2019-06-06 |
| Companies | Position | End |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 2014-12-31 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Cipher Pharmaceuticals, Inc.
Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Health Technology |
Edesa Biotech, Inc.
Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Edesa Biotech Research, Inc. |
Select your edition
All financial news and data tailored to specific country editions